scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.ASN.0000013300.11876.37 |
P698 | PubMed publication ID | 11961010 |
P50 | author | Lana Strmecki | Q54867395 |
P2093 | author name string | Sarah Burton | |
Peter C Harris | |||
Vicente E Torres | |||
Gregory R Pond | |||
Seza Ozen | |||
Sandro Rossetti | |||
Klaus Zerres | |||
Erik J Bergstralh | |||
Christopher G Winearls | |||
T Martin Barratt | |||
Jośe L San Millán | |||
P433 | issue | 5 | |
P921 | main subject | polycystic kidney disease 1 | Q32143916 |
polycystic kidney disease | Q60195313 | ||
P304 | page(s) | 1230-1237 | |
P577 | publication date | 2002-05-01 | |
P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
P1476 | title | The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease | |
P478 | volume | 13 |
Q55184446 | A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation. |
Q33926310 | A missense mutation in PKD1 attenuates the severity of renal disease |
Q36781051 | A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells |
Q42696397 | A potentially crucial role of the PKD1 C-terminal tail in renal prognosis |
Q40242639 | A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression |
Q36345737 | ADPKD: molecular characterization and quest for treatment |
Q45106061 | Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes. |
Q37345965 | Advances in management of polycystic liver disease |
Q95413886 | Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study |
Q54101556 | Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. |
Q55898854 | Autosomal dominant polycystic kidney disease |
Q35661408 | Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). |
Q34621895 | Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele. |
Q34208664 | CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation. |
Q33817900 | Clinical and public health implications of emerging genetic technologies |
Q34366204 | Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic |
Q33723857 | Determinants of renal disease variability in ADPKD. |
Q36505469 | Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease |
Q28079746 | Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease |
Q36926935 | Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease |
Q44084000 | Enos polymorphism and renal disease progression in autosomal dominant polycystic kidney disease. |
Q43074229 | Family history of renal disease severity predicts the mutated gene in ADPKD. |
Q35194509 | Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). |
Q47781166 | Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases |
Q38978453 | Genetic Mechanisms of ADPKD. |
Q34455341 | Genetic variation of DKK3 may modify renal disease severity in ADPKD. |
Q38255110 | Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. |
Q48964037 | Genetics and phenotypic characteristics of autosomal dominant polycystic kidney disease in Finns |
Q38219509 | Hereditary polycystic kidney disease: genetic diagnosis and counseling |
Q36343363 | Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease |
Q42927109 | Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease |
Q37697510 | Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat. |
Q91834933 | Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model |
Q35827271 | Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. |
Q44459183 | Laparoscopic removal of renal cysts in patients with ADPKD as an alternative method of treatment and patient preparation for kidney transplantation: preliminary results. |
Q24633724 | Liver and kidney disease in ciliopathies |
Q37294781 | Loss of polycystin-1 causes centrosome amplification and genomic instability |
Q81382267 | Management of polycystic liver disease |
Q33723862 | Molecular advances in autosomal dominant polycystic kidney disease |
Q34100184 | Molecular diagnostics for autosomal dominant polycystic kidney disease |
Q36666944 | Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations |
Q35578646 | Molecular pathways and therapies in autosomal-dominant polycystic kidney disease |
Q91854374 | Monkeys mutant for PKD1 recapitulate human autosomal dominant polycystic kidney disease |
Q44624885 | NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease. |
Q33494204 | New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease |
Q44009665 | Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease |
Q24799068 | Novel and de novo PKD1 mutations identified by multiple restriction fragment-single strand conformation polymorphism (MRF-SSCP) |
Q35138042 | Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease. |
Q38273327 | Novel therapeutic approaches to autosomal dominant polycystic kidney disease |
Q37362069 | Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury |
Q28283470 | Polycystic disease of the liver |
Q33709685 | Polycystic kidney disease |
Q36336546 | Polycystic liver and kidney diseases |
Q28505110 | Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells |
Q38914739 | Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease |
Q90672124 | Prediction of Progression in Polycystic Kidney Disease Using the Kidney Failure Risk Equation and Ultrasound Parameters |
Q92705688 | Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations |
Q37005478 | Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history |
Q35125247 | Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease |
Q47426725 | Recent advances in management of autosomal-dominant polycystic kidney disease |
Q36454608 | Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD. |
Q51741625 | The diversity of PKD1 alleles: implications for disease pathogenesis and genetic counseling. |
Q36880400 | Type of PKD1 mutation influences renal outcome in ADPKD. |
Q52571078 | Vascular Endothelial Growth Factor (VEGF) Gene Promoter Polymorphisms and Disease Progression in North Indian Cohort with Autosomal Dominant Polycystic Kidney Disease. |
Search more.